Creative Medical Technology Holdings (Creative Medical Technology Holdings) Change In Working Capital : $-2.84 Mil (TTM As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Creative Medical Technology Holdings Change In Working Capital?

Creative Medical Technology Holdings's change in working capital for the quarter that ended in Dec. 2023 was $-0.22 Mil.

Creative Medical Technology Holdings's change in working capital for the fiscal year that ended in Dec. 2023 was $-2.84 Mil.

It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement. Not by calculating the number changes in each periods' working capital (Total Current Assets minus Total Current Liabilities).

Creative Medical Technology Holdings Change In Working Capital Historical Data

The historical data trend for Creative Medical Technology Holdings's Change In Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Creative Medical Technology Holdings Change In Working Capital Chart

Creative Medical Technology Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Working Capital

Get a 7-Day Free Trial

0.06

0.69

0.25

2.19

-2.84

Creative Medical Technology Holdings Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Working Capital	Get a 7-Day Free Trial															2.59	-2.82	0.08	0.12	-0.22

Creative Medical Technology Holdings Change In Working Capital Calculation

Change In Working Capital for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.84 Mil.

Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities.

Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement.

Use Wal-Mart Stores Inc (Jan 2014, Annual Data) as an example: Source: Wal-Mart Stores Inc 2014-01-31 10-K from SEC

Consolidated Statements of Cash Flows	Fiscal Years Ended	January 31,	(Amounts in millions)
Cash flows from operating activities:	2014	2013	2012
Changes in certain assets and liabilities, net of effects of acquisitions:
Receivables, net	(566)	(614)	(796)
Inventories	(1,667)	(2,759)	(3,727)
Accounts payable	531	1,061	2,687
Accrued liabilities	103	271	(935)
Accrued income taxes	(1,224)	981	994

For 2014-01-31, add all the items under 2014 collum together, Change in Working Capital was (566) + (1,667) + 531 + 103 + (1,224) = $ (2,823) Mil.

Creative Medical Technology Holdings Change In Working Capital Related Terms

Thank you for viewing the detailed overview of Creative Medical Technology Holdings's Change In Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Creative Medical Technology Holdings (Creative Medical Technology Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Creative Medical Technology Holdings Inc (NAS:CELZ) » Definitions » Change In Working Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

211 E Osborn Road, Phoenix, AZ, USA, 85012

Website

https://www.creativemedicaltechnology.com

Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid-derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.

Executives

Timothy Warbington	director, 10 percent owner, officer: President & CEO	211 E. OSBORN ROAD, PHOENIX AZ 85012
Michael H. Finger	director	1551 N. DIANE ST., MESA AZ 85203-3850
Susan H Snow	director	26 SEDGE FERN DRIVE, HILTON HEAD SC 29926
Bruce Steven Urdang	director	5171 E. HAWTHORNE DR., FLAGSTAFF AZ 86004-7377
Thomas Ichim	director	211 E. OSBORN RD, PHOENIX AZ 85012
Creative Medical Health Inc.	10 percent owner	211 E. OSBORN RD, PHOENIX AZ 85012
Timothy Herbst	10 percent owner	2031 W. PEORIA AVE., SUITE 250, PHOENIX AZ 85029
Amit Nilkanth Patel	director	1040 CHARTWELL CT., SALT LAKE CITY UT 84121
Donald Dickerson	director, officer: CFO & Sr.VP	822 VERA STREET, SOLANA BEACH CA 92075
Steven L White	director, officer: President,Secretary,Treasurer	386 NORTH 210 EAST, MAPLETON UT 84664